Search research articles
Contact Us
Filters
Showing results (471-480 of 583) with videos related to
Page
of 59
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2008
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study
Guido Marcucci, Kati Maharry, Michael D Radmacher, et al.
Blood
|
November 3, 2009
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Döhner, Elihu H Estey, Sergio Amadori, et al.
Haematologica
|
August 16, 2019
Mutations associated with a 17-gene leukemia stem cell score and the score's prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia
Marius Bill, Deedra Nicolet, Jessica Kohlschmidt, et al.
Blood
|
August 22, 2008
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia
Klaus H Metzeler, Manuela Hummel, Clara D Bloomfield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2013
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia
Xiaomeng Huang, Sebastian Schwind, Bo Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2005
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity
Guido Marcucci, Wendy Stock, Guowei Dai, et al.
Leukemia
|
June 7, 2018
NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome
Ann-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2019
EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia
Marius Bill, Aparna Pathmanathan, Malith Karunasiri, et al.
Blood Advances
|
July 12, 2018
Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission
Sumithira Vasu, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Cancer
|
February 7, 2025
Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study
Marlise R Luskin, Jun Yin, Gerard Lozanski, et al.
Page
of 59
Search research articles
Search
Showing results (471-480 of 583) with videos related to
Sort By:
Page
of 59
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2008
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study
Guido Marcucci, Kati Maharry, Michael D Radmacher, et al.
Blood
|
November 3, 2009
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Döhner, Elihu H Estey, Sergio Amadori, et al.
Haematologica
|
August 16, 2019
Mutations associated with a 17-gene leukemia stem cell score and the score's prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia
Marius Bill, Deedra Nicolet, Jessica Kohlschmidt, et al.
Blood
|
August 22, 2008
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia
Klaus H Metzeler, Manuela Hummel, Clara D Bloomfield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2013
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia
Xiaomeng Huang, Sebastian Schwind, Bo Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2005
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity
Guido Marcucci, Wendy Stock, Guowei Dai, et al.
Leukemia
|
June 7, 2018
NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome
Ann-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2019
EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia
Marius Bill, Aparna Pathmanathan, Malith Karunasiri, et al.
Blood Advances
|
July 12, 2018
Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission
Sumithira Vasu, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Cancer
|
February 7, 2025
Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study
Marlise R Luskin, Jun Yin, Gerard Lozanski, et al.
Page
of 59